Innoviz Technologies to Present at Upcoming Investor Conferences
Get Alerts INVZ Hot Sheet
Join SI Premium – FREE

- Deutsche Bank's Global Auto Industry Conference - Senior management will attend the conference at the Deutsche Bank Center in
New York , meet with investors in-person, and participate in a fireside chat moderated by Deutsche Bank, onJune 14, 2023 at1:35pm - 2:10pm ET . Registration for the live webcast of the event is available here. - Cantor Fitzgerald Technology Conference - Senior management will attend the conference in
New York and hold individual meetings with investors. Management will also hold a formal panel presentation titled 'LIDAR, Radar & the Adoption of Autonomous Vehicles' onJune 15, 2023 at3:50pm - 4:30pm ET . Live webcasting is not being offered at this conference.
About Innoviz Technologies
Innoviz is a global leader in LiDAR technology, working towards a future with safe autonomous vehicles on the world's roads. Innoviz's LiDAR and perception software "see" better than a human driver and reduce the possibility of error, meeting the automotive industry's strictest expectations for performance and safety. Operating across the
Join the discussion: Facebook, LinkedIn, YouTube, Twitter
Media Contact
Investor Contact (US) Investor Contact (
Rob Moffatt
VP, Corporate Development & IR Director, Investor Relations
Innoviz Technologies Innoviz Technologies
+1 (203) 665-8644 +972 54 677 8100
[email protected] [email protected]
Logo - https://mma.prnewswire.com/media/1496323/Innoviz_Technologies_Logo.jpg
View original content:https://www.prnewswire.com/news-releases/innoviz-technologies-to-present-at-upcoming-investor-conferences-301848034.html
SOURCE Innoviz Technologies
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EVERSANA Expands AI-Powered Commercialization Platform with New Capabilities Across Medical Affairs, Market Research and Commercial Operations
- R. Rex Parris and Khail A. Parris Earn 2027 Best Lawyers Honors
- Rhelion Life Sciences' Wholly Owned Subsidiary Filament Health Signs Letter of Intent with Darmiyan, Inc. to Explore Use of FDA De Novo Authorized BrainSee(R) AI Platform in Early Alzheimer's Disease
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
Deutsche Bank, Cantor Fitzgerald, TwitterSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share